News

Adults diagnosed with bipolar disorder are much more likely than the general population to have suffered emotional, physical, or sexual abuse as children.

German researchers need more data before they can decide whether the hepatitis drug combo sofosbuvir/velpatasvir (Epclusa/Gilead Sciences) is better than earlier antivirals for all genotypes of hepatitis C virus.

Researchers report there is evidence of a correlation between immune recovery and the behavior of a certain subset of gut bacteria in patients with HIV treated with antiretroviral therapy.

Patients with active psoriatic arthritis treated with secukinumab for 2 years in the FUTURE-1 trial experienced sustained decreases in disease activity and symptoms, leading to improvements in physical function and quality of life.

Physicians trying to set an all-clear point for would-be parents who have been infected with the Zika virus simply do not know how long abstention from unprotected sex is necessary. In the latest reported case involved the virus' persistence in semen, UK researchers describe a patient whose virus was found 92 days after he got Zika on a trip to Rio De Janeiro

The risk of getting Non-Hodkins Lymphoma is greater in patients co-infected with hepatitis B and hepatitis C if those patients are also receiving anti-retroviral therapy for HIV infection.

Fibromyalgia is notoriously difficult to diagnose. But a new study from the University of Colorado Boulder (CU Boulder) may have found a brain signature that red flags the disease.

Patients experiencing pain from irritable bowel syndrome (IBS) might find relief from an unlikely source.

The FDA has approved Genentech's prefilled ranibizumab syringe for injecting the eyes of people with wet age-related macular degeneration (wet AMD)

There are many challenges that confront pain specialists on a daily basis. Despite those challenges, seeing their patients recover and live a better quality of life is reward enough to keep them optimistic for the future of the field.

Injectable medications are being used for everything from chronic pain to cancer related pain. While doctors are working to help their patients manage their symptoms they are also keeping a close eye on potential abuse and illegal activity with the medication.

Ketamine is not a new tool in the arsenal of pain medication but doctors are finding new ways to use it in order to provide relief for patients. As an infusion ketamine is being used to treat chronic pain syndromes.

In an effort to avoid prescribing opioids except in cases where they are needed doctors are finding new ways to provide relief for their patients. This can include newly developed implantable medications which can help reduce pain and increase quality of life.

Eric Simpson, MD, the lead author on the study, spoke to MD Magazine about the results, which showed great improvement with few side effects for those with moderate or severe atopic dermatitis.

When opioids first hit the market they were specifically promoted for their non-addictive traits. Over the past few decades that has been disproven as doctors look for the best way to treat patients and avoid the risk of unwanted addiction and other issues.

As the main treatment in pain medication opioids are widely prescribed for patients who need them. Balancing that with the risk of addiction and abuse is something providers deal with on a regular basis.

According to findings published in Stem Cells, Intestinal homeostasis could be one of the mechanisms responsible for atypical celiac disease and colorectal cancer.

Diagnosing children with autism could get easier – by introducing the user of iPad games into the process, according to findings published in Scientific Reports.

Many major hospitals that admit varied patients with a wide breadth of ailments, including the Hospital of the University of Pennsylvania and Mount Sinai Hospital in New York City, have high rates of Clostridium difficile (C. difficile) infection, according to the report.

The authors assert that “there remains a need to identify inexpensive and non-toxic therapies that target the underlying pathophysiology of autoimmune disorders” and that “Blockade of the opioid growth factor (OGF)-OGF receptor (OGFr) pathway with low dose naltrexone (LDN) has been explored as one such therapy.”

There are different subtypes of the human immunodeficiency virus (HIV), and the one at the forefront of the epidemic is actually the one that replicates very slowly.

Stroke patients stayed in the rehabilitation facilities for an average of about 16 days, but half of the patients were discharged about one day earlier than expected. Patients without social support were typically associated with lower odds of a short stay in the group of stroke patients.

There are any number of diets aimed at helping people lose weight. A recent study looked at whether a fasting diet was the way to go for the best results.

A large observational study of results in routine clinical practice showed that visual acuity outcomes 12 months after Aflibercept or Ranibizumab treatment did not differ, and neither did the number of injections required for each agent.

The North American Menopause Society is involved in many aspects of patient care with each effort working toward the common goal of improving treatment for women before, during, and after menopause.

The only factor that predicted visual outcomes one year after nAMD diagnosis was baseline visual acuity, which maintained its predictive ability five years after diagnosis. Visual acuity increased more frequently in women.

A common symptom reported by many women as they transition through menopause is issues with cognition. Whether it is described as a "mental fog," or "forgetfulness. Taking these concerns seriously is an issue confronted by many providers who treat these women.

The investigational drug that AbbVie is testing in clinical trials is a pan-genotypic regimen of glecaprevir and pibrentasvir, a co-formulation dosed once a day, according to the release.

The researchers report that “rituximab was relatively well tolerated," though complications were reported.

Future treatment options for stomach ulcers, inflammatory bowel disease, and alcoholic liver disease can come from stem cell transplants, according to a series of new studies.